Cargando…
High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is the major type of esophageal cancer in Asia and demonstrates poor survival rates following a therapeutic regimen. METHODS: Cancer stem cells (CSCs) are responsible for tumor initiation, progression, and treatment failure in cancers. Therefore,...
Autores principales: | Lin, Cheng-Han, Li, Hao-Yi, Liu, Yu-Peng, Kuo, Pei-Fung, Wang, Wen-Ching, Lin, Forn-Chia, Chang, Wei-Lun, Sheu, Bor-Shyang, Wang, Yi-Ching, Hung, Wan-Chun, Cheng, Hui-Chuan, Yao, Yun-Chin, Calkins, Marcus J., Hsiao, Michael, Lu, Pei-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767752/ https://www.ncbi.nlm.nih.gov/pubmed/31632466 http://dx.doi.org/10.1177/1758835919875324 |
Ejemplares similares
-
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma
por: Lin, Cheng-Han, et al.
Publicado: (2016) -
Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
por: Yang, Pei-Wen, et al.
Publicado: (2019) -
Pin1 positively affects tumorigenesis of esophageal squamous cell carcinoma and correlates with poor survival of patients
por: Lin, Forn-Chia, et al.
Publicado: (2014) -
Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma
por: Lee, Yu-Cheng, et al.
Publicado: (2022) -
Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding
por: Cheng, Hsiu-Chi, et al.
Publicado: (2011)